#Pharmaceuticals
Total 2 articles
TechEN
AstraZeneca's $100M Bet Shows China's Pharma Industry Is Flipping the Script
AstraZeneca's $100 million upfront payment to China's Jacobio Pharma for a novel drug signals a major shift. The deal shows China's evolution from a generics maker to a key source of pharma innovation.
EconomyEN
The Pharma Paradox: Why Big Pharma's $171B Patent Cliff Leads Straight to China
Big Pharma faces a $171B revenue cliff. Their solution? Chinese biotech. Our analysis unpacks the high-stakes clash between economic need and geopolitical risk.